Clovis Oncology Inc CLVS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:44 PM EDT
4.57quote price arrow down-0.27 (-5.58%)
Volume
2,275,416
52 week range
4.06 - 11.10
Loading...
  • Open4.59
  • Day High4.76
  • Day Low4.53
  • Prev Close4.84
  • 52 Week High11.10
  • 52 Week High Date02/08/21
  • 52 Week Low4.06
  • 52 Week Low Date08/19/21

Key Stats

  • Market Cap541.13M
  • Shares Out118.41M
  • 10 Day Average Volume4.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.76
  • YTD % Change-4.28

KEY STATS

  • Open4.59
  • Day High4.76
  • Day Low4.53
  • Prev Close4.84
  • 52 Week High11.10
  • 52 Week High Date02/08/21
  • 52 Week Low4.06
  • 52 Week Low Date08/19/21
  • Market Cap541.13M
  • Shares Out118.41M
  • 10 Day Average Volume4.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.76
  • YTD % Change-4.28

RATIOS/PROFITABILITY

  • EPS (TTM)-3.16
  • P/E (TTM)-1.45
  • Fwd P/E (NTM)-2.51
  • EBITDA (MRQ)-242.37M
  • ROE (MRQ)-547.55%
  • Revenue (MRQ)156.94M
  • Gross Margin (MRQ)74.61%
  • Net Margin (MRQ)-197.75%
  • Debt To Equity (MRQ)-312.82%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Clovis Oncology Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is marketed in the United States for two indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The Company...
Ginger Graham
Non-Executive Chairman
Patrick Mahaffy
President
Daniel Muehl CPA
Chief Financial Officer
Ann Bozeman
Executive Vice President
Paul Gross J.D.
Executive Vice President
Address
5500 Flatiron Pkwy Unit 100
Boulder, CO
80301-2834
United States

Top Peers

SYMBOLLASTCHG%CHG
RIGL
Rigel Pharmaceuticals Inc
3.70-0.19-5.00%
CPRX
Catalyst Pharmaceuticals Inc
4.85-0.20-3.96%
CARA
Cara Therapeutics Inc
15.14-0.11-0.72%
ATNX
Athenex Inc
3.33-0.17-5.00%
FGEN
FibroGen Inc
11.21-0.48-4.11%